Skip to main content

  • New presbyopia IOL receives CE Mark

    AcuFocus, Inc.
    Comprehensive Ophthalmology, Refractive Mgmt/Intervention
    Add to My Bookmarks

    AcuFocus’ IC-8 small aperture IOL for presbyopic patients with cataract has received the CE Mark in Europe.

    The company plans to make the IC-8 available through a controlled release in select markets across Europe. The IOL is not approved for use in the United States.

    The IC-8 was designed to address the limitations of other presbyopia treatments, such as incomplete range of vision, visual quality degradation from induced glare and halo, and loss of binocular contrast, and to deliver high quality, continuous functional vision.

    AcuFocus’ Kamra inlay uses the small aperture effect to treat presbyopia by improving near vision while maintaining distance vision. By applying the same principle, the company hopes the IC-8 will boost the number of patients who can benefit from small aperture optics to those undergoing cataract surgery or refractive lens exchange.

    “The small aperture effect is a globally accepted method for vision correction,” said Jim Mazzo, chairman and CEO of AcuFocus. “The Kamra inlay is the ideal solution for presbyopic patients who don’t want or require lens removal. With the addition of the IOL to our patented small aperture portfolio, we can now provide cataract patients with the same exceptional vision.”